Abstract
Introduction
Telemedicine and its use in medical toxicology have existed for some time. There are varied definitions, but existing ones center on using currently available forms of audio, video, and internet communications to provide “real-time” patient care. Definitions have historically limited reimbursement but recently expanded CMS guidelines have improved this. Here we describe our experience with telemedicine and reimbursement.
Methods
A retrospective study was conducted of all toxicology and billing reimbursement for fiscal year 2016 for a solo Medical Toxicology service. Clinical identifiers were used to match telemedicine consults to hospital financial databases and then removed. Telemedicine consults were isolated, quantified, and described.
Results
A total of 16 telemedicine consults were conducted. Average age was 37.2 (range 2 months–82 years). Gender was evenly split at 8:8. Twenty-five percent were pediatric consultations. The main purposes of consultation were as follows: diagnosis and disease management in drug ingestion, triage assistance, clearance consults, antidote administration, and buprenorphine induction. At the time of the work, $1896.00 for 9.3 h of teletoxicology services was reimbursed equating to an hourly reimbursement rate of $203.90/h.
Limitations
Our data was obtained from a toxicology practice with a surrounding infrastructure dedicated to telemedicine. All sites may not have this robust ancillary support. Furthermore, not all states have reimbursement mandates such as New York State.
Conclusion
To our knowledge, this is the first published work describing pilot data in the successful reimbursement for Medical Toxicology services delivered via telemedicine. Toxicology via telemedicine represents a great opportunity for advancing the practice of toxicology in an economically feasible way, particularly in rural or underserved areas.
Similar content being viewed by others
References
McManus J, Salinas J, Morton M, Lappan C, Poropatich R. Teleconsultation program for deployed soldiers and healthcare professionals in remote and austere environments. Prehosp Disaster Med. 2008;23(3):210–6. discussion 217
Klonoff DC. Using telemedicine to improve outcomes in diabetes—an emerging technology. SAGE Publications; 2009.
Deldar K, Bahaadinbeigy K, Tara SM. Teleconsultation and clinical decision making: a systematic review. Acta Inform Med. 2016;24(4):286–92.
Strode SW, Gustke S, Allen A. Technical and clinical progress in telemedicine. JAMA. 1999;281(12):1066–8.
Price M. Towards a better connection: a federally-led uniform reimbursement scheme for telemedicine. 2017.
Beach F. 2015 ACMT Annual Scientific Meeting, March 27–29, 2015 clearwater. J Med Toxicol. 2015;11:2–47.
Bass RJ, editor. “Expanded coverage of telemedicine”. telehealth & telemedicine: progress and barriers in New York. Albany Law School; 2014.
Vohra RMG, editor. Is it primetime for facetime? Video telephone app use in toxicology consultations. 2014 ACMT Annual Scientific Meeting—March 28–30, 2014 Phoenix, AZ, USA; 2014; Pheonix, AZ. J. Med. Toxicol.
Center CfCHPTNTPR. State Telehealth Laws And Reimbursement Policies: a comprehensive scan of the 50 states and district of Columbia 2017 [cited 2018 January 30]. Available from: http://www.cchpca.org/sites/default/files/resources/50%20STATE%20PDF%20FILE%20APRIL%202017%20FINAL%20PASSWORD%20PROTECT.pdf.
Moore P, Suda K, Caicedo C-A. Establishing a telemedicine toxicology service using an established interac-ve audio—visual consult network. Crit Care. 2014;188:75min.
Chai PR, Babu KM, Boyer EW. The feasibility and acceptability of Google Glass for teletoxicology consults. J Med Toxicol. 2015;11(3):283–7.
Chai PR, Wu RY, Ranney ML, Porter PS, Babu KM, Boyer EW. The virtual toxicology service: wearable head-mounted devices for medical toxicology. J Med Toxicol. 2014;10(4):382–7.
Skolnik AB, Chai PR, Dameff C, Gerkin R, Monas J, Padilla-Jones A, et al. Teletoxicology: patient assessment using wearable audiovisual streaming technology. J Med Toxicol. 2016;12(4):358–64.
Leikin JB, Vogel S, Samo D, Stevens P, Walter FG. Reimbursement profile of a private toxicology practice. Clin Toxicol. 2006;44(3):261–5.
Wiegand TJ, Crane PW, Kamali M, Reif M, Wratni R, Montante R, et al. Billing and reimbursement for a bedside toxicology service at a tertiary care academic center during its first fiscal year. J Med Toxicol. 2015;11(1):48–58.
Funding
None
Author information
Authors and Affiliations
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Crane, P.W., Wiegand, T.J., Kamali, M. et al. Telemedicine Delivery and Successful Reimbursement in Toxicology. J. Med. Toxicol. 14, 242–247 (2018). https://doi.org/10.1007/s13181-018-0665-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-018-0665-5